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Abstract 22 
Xylo-oligosaccharides and xylo-polysaccharides (XOS, XPS) produced by autohydrolysis 23 
of the fibre from oil palm empty fruit bunches (OPEFB) were purified using gel filtration 24 
chromatography to separate the XOS and XPS from the crude autohydrolysis liquor. Six 25 
mixed fractions of refined XOS and XPS with average degree of polymerisation (avDP) of 26 
4-64 were obtained. These were characterised in terms of their composition and size by 27 
HPLC, MALDI-ToF-MS (selected fractions) and carbohydrate gel electrophoresis (PACE). 28 
They were assessed in batch culture fermentations using faecal inocula to determine their 29 
ability to modulate the human faecal microbiota in vitro by measuring the bacterial growth, 30 
organic acid production and the XOS assimilation profile. The gut microbiota was able to 31 
utilise all the substrates and there was a link between the XOS/XPS degree of 32 
polymerisation with the fermentation properties. In general, XOS/XPS preparations of 33 
lower avDP promote better Bifidobacterium growth and organic acid production.  34 
 35 
Keywords 36 
Autohydrolysis; in vitro fermentation; Oil palm empty fruit bunches; Xylo-oligo and xylo-37 
polysaccharides 38 
 39 
1. Introduction 40 
The benefits of non-digestible oligosaccharides (NDOs) in modulating the intestinal 41 
and colonic microbiota that have an effect on human gut health have been well established 42 
and the study of NDOs derived from plant cell walls as emerging prebiotics has raised 43 
much interest.  This is because plant cell walls, especially derived from cereal grains, are 44 
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part of our dietary fibre intake; the particular components of plant cell walls of interest in 45 
the context of prebiotics are the hemicelluloses. Hemicelluloses are the second most 46 
abundant class of polysaccharides available in the plant kingdom with xylan being the most 47 
common. Xylans have a backbone of β-(14) linked xylose units that are often substituted 48 
with arabinose, methylated or non-methylated glucuronic acid, acetic acid or ferulic acid 49 
(Ebringerová, Hromadkova & Heinze, 2005). Thus, depending on the origin of the plant 50 
cell wall and treatment process, various xylo-oligosaccharides (XOS, avDP  20) or xylo-51 
polysaccharides (XPS, avDP > 20) with or without branching can be obtained. 52 
 In this regard, plant lignocellulosic biomass generated at the agricultural field and 53 
processing plant, which was once considered as waste for disposal, offers an enormous 54 
potential resource as a basic feedstock for XOS production (Moure, Gullón, Domínguez & 55 
Parajó, 2006). In the context of biorefining, hydrothermal treatments such as autohydrolysis 56 
have been investigated as an initial step of a possible multi-stage process for the utilisation 57 
of lignocellulosic materials, as it can produce soluble oligosaccharides, leaving cellulose 58 
and lignin in the solid phase for other usage (Parajó, Garrote, Cruz & Domínguez, 2004). 59 
The XOS obtained from autohydrolysis treatment also retain some substituents that are 60 
present in the native xylan such as acetyl groups, which could have an effect on their 61 
fermentability by the human intestinal microbiota (Kabel, Schols & Voragen, 2002b).  62 
Earlier studies on the ability of XOS to modulate the intestinal microbiota 63 
investigated linear XOS of small molecular weight with a DP around 2-3. The low 64 
molecular weight XOS significantly promoted the growth of bifidobacteria and led to an 65 
increase in short chain fatty acid (SCFA) production in the bacterial cultures (Crittenden et 66 
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al., 2002; Okazaki, Fujikawa & Matsumoto, 1990; Palframan, Gibson & Rastall, 2003a) 67 
and in in vivo studies in humans and animals (Campbell, Fahey & Wolf, 1997; Childs et al., 68 
2014; Chung, Hsu, Ko & Chan, 2007). Pure culture studies using XOS from corn cob and 69 
rice husk autohydrolysis with DP  4 also enhanced the growth of bifidobacteria despite 70 
having some acetyl groups and/or uronic acid substituents (Gullón et al., 2008; Moura et 71 
al., 2007). In Kabel, Kortenoeven, Schols & Voragen (2002a), a XOS preparation with 72 
wider range mixed DP (DP 2-11) was used and when fermented in vitro with human faecal 73 
inocula, the substrate was almost completely degraded in 20-40 h of fermentation. The 74 
fermentation rate and the SFCA profiles however varied depending on the substituents that 75 
were present, whereby the linear XOS and arabinose substituted XOS (AXOS) were 76 
fermented faster than acetylated XOS and methylglucuronylated XOS was the slowest.  The 77 
bacteriology profile however was not the focus in that study, so the way the substituents 78 
modulate the gut microbiota is unknown. Increases in potentially health-positive bacterial 79 
groups such as Bifidobacterium spp. and Lactobacillus/Enterococcus spp. were seen with 80 
high average molecular weight arabinoxylans of 66,278 and 354 kDa (Hughes, Shewry, Li, 81 
Gibson, Sanz & Rastall, 2007). However, the arabinoxylans tested also significantly 82 
promoted clostridial growth. Van Craeyveld (2008) in a more systematic study on the 83 
influence of the average degree of polymerisation (avDP) and average degree of arabinose 84 
substitution (avDAS) of XOS preparation in the cecum of rats, showed that low molecular 85 
weight AXOS (avDP-avDAS of 5-0.27 and 3-0.26) increased Bifidobacterium spp. 86 
significantly more than high molecular weight AXOS (avDP –avDAS of 61-0.58). On the 87 
other hand, the measured branched SCFA was the lowest with avDP 61, so this could 88 
potentially suppress the metabolites from protein fermentation. 89 
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In a previous study, results have demonstrated that it is possible to produce purified 90 
XOS fractions of a variety of avDP from oil palm biomass autohydrolysis liquor (Ho et al., 91 
2014). The aim of this work was to study the effect of XOS and XPS obtained from 92 
purification of autohydrolysed OPEFB at different avDP 4-64 upon the gut microbiota 93 
population. The rationale for inclusion of higher avDP XOS/XPS preparations in this study 94 
is they may have better persistence into the distal colon, with potential benefits to chronic 95 
gut diseases.  96 
 97 
2. Materials and methods 98 
2.1 Preparation of XOS/XPS fractions 99 
The XOS/XPS preparation was according to Ho et al. (2014). Briefly, the fibre of 100 
dried oil palm empty fruit bunches (OPEFB) was subjected to non-isothermal 101 
autohydrolysis treatment in a two litre capacity stainless steel reactor (Parr Instruments Co., 102 
llinois, United States) with an operational temperature 210 oC and a liquid to solid ratio of 8 103 
(w/w). The liquor obtained from autohydrolysis treatment was filtered and purified using 104 
preparative gel filtration chromatography (GFC) (Ho et al., 2014) with a BPG 100/950 105 
column filled with Superdex 30TM (Amersham Pharmacia Biotech, Uppsala, Sweden). The 106 
liquid fractions were freeze dried and then pooled together to obtained six mixed freeze-107 
dried XOS/XPS with a range of avDP. 108 
 109 
2.2 Characterization of XOS/XPS fractions 110 
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Prior to the determination of average molar mass and chemical compositions, the 111 
XOS/XPS samples were dissolved in deionised water to obtain a concentration of 10 g/L. 112 
The apparent molar mass of samples was determined by high performance liquid 113 
chromotography (HPLC) (Agilent 1100 series, Winnersh, UK). A size exclusion column 114 
BIOSEP-SEC S2000 (Phenomenex, Cheshire, UK) was used at 30 oC with 50 mM NaNO3 115 
as mobile phase at 0.7 mL/min. The eluate was detected using a refractive index (RI) 116 
detector. External standards with different molecular weights, i.e. xylose, 117 
maltooligosaccharides (DP 2-5) and dextrans (1-71 kDa, Sigma, Dorset, UK) were used for 118 
calibration.  119 
The composition of the XOS/XPS samples was assayed by HPLC to quantify free 120 
monosaccharides (glucose, xylose and arabinose), aliphatic acids (acetic acid, formic acid 121 
and levulinic acid) and furan derivatives (furfural and 5-hydroxymethylfurfural, HMF) 122 
compounds. An Aminex HPX-87H column (BioRad, Hemel Hempstead, UK) was used at 123 
50 oC with 5 mM H2SO4 as mobile phase. The monosaccharides and aliphatic acids were 124 
detected with a RI detector while furfural and HMF were detected using a diode array 125 
detector (DAD) at 280 nm. 126 
The oligosaccharide content was determined by an indirect method using 127 
quantitative acid hydrolysis; this was done by mixing the XOS/XPS sample with H2SO4 128 
(72 % w/w) to obtain a final acid concentration of 4 % (w/w) and the sample was heated at 129 
121 oC for 60 min to induce hydrolysis. The post hydrolysed liquor was analysed with 130 
HPLC and the oligosaccharide concentration was expressed as the increase in sugar 131 
monomers (Sluiter et al., 2006). 132 
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The total phenolic content was assayed spectrophometrically by the Folin Ciocalteu 133 
method using gallic acid as standard (Singleton & Rossi, 1965). 134 
 135 
2.3 MALDI-Tof-MS of XOS fractions 136 
MALDI-ToF-MS was used to analyse the extracted OPEFB XOS fractions in native 137 
and permethylated form for XOS avDP 4, 7 and 14. Initial analysis of the native fractions 138 
did not produce strong signals (Figure S1) so analyses were also performed with 139 
permethylated fractions. Permethylation of XOS fractions was performed using the 140 
NaOH/DMSO slurry method using 0.5 mL of methyl iodide (Ciucanu & Kerek, 1984). 141 
Permethylated glycans were dried under a stream of nitrogen and re-dissolved in 100 µL of 142 
methanol. Five µL of native or permethylated XOS fractions (10 mg/mL) were mixed with 143 
5 µL of 2, 5-dihydroxybenzoic acid (DHB, 10 mg/mL dissolved in 50 % MeOH with 1% 144 
TFA, v/v) matrix. One µL of native or permethylated glycans mixed with DHB matrix was 145 
spotted onto a MALDI target plate and allowed to air-dry. MALDI-ToF-MS was carried 146 
out using a Micromass MALDI-LR mass spectrometer (Waters, Manchester, UK) using a 147 
mass acquisition between m/z 450 and 3 000. The MALDI set-up was as described by 148 
Marsh et al. (2011). Glycan adduct ions [M + Na]+ were assigned. Experimentally 149 
determined masses were interpreted using GlycoMod (ExPaSy). 150 
 151 
2.4 Analysis of XOS/XPS fractions by carbohydrate gel electrophoresis 152 
Polysaccharide Analysis by Carbohydrate Gel Electrophoresis (PACE) was used to 153 
analyse the extracted OPEFB XOS/XPS fractions. Fractions were run with and without 154 
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digestion with xylanase 11. Briefly, for xylanase digested samples, 200 µg aliquots were 155 
digested with Xyn11 (4 µL ≈ 21.92 µg; Prozomix, UK) for 16 h at 40 °C in total volume of 156 
500 µL. Digestion was terminated by boiling the samples for 30 min and samples were 157 
dried in vacuo. Aliquots (200 µg) of undigested XOS/XPS fractions were also dried down. 158 
All samples together with standard xylo-oligosaccharides (Xyl1-6; Megazyme, Ireland) were 159 
labelled with ANTS and ran on acrylamide gel as described by Kosik, Bromley, Busse-160 
Wicher, Zhang & Dupree (2012). Gels were visualized under UV light using a GelDoc-It 161 
TS2 imager (UVP, Germany) equipped with a GFP emission filter (513-557 nm).   162 
 163 
2.5 In vitro batch fermentation  164 
The six different fractions of XOS/XPS along with commercial XOS (avDP2, 165 
Shandong Longlive Biotechnology Co. Ltd (SLBC), China) and birch wood xylan (Sigma, 166 
Dorset, UK) were evaluated for the ability to modulate the gut microbiota using an in vitro 167 
batch culture fermentation system inoculate with human faecal sample. 168 
Fructooligosaccharides (avDP 4, Raftilose, Orafti, Tienan, Belgium) were used as the 169 
positive control. The in vitro fermentation was carried out a 50 mL working volume glass 170 
jacketed bioreactors, sterile of stirred batch culture fermentation system. The carbohydrates 171 
sources were added at 1 % (w/v). The basal medium (per litre) consisted of: 2 g peptone 172 
water, 2 g yeast extract, 0.1 g NaCl, 0.04 g K2HPO4, 0.04 g KH2PO4, 0.01 g MgSO4.7H2O, 173 
0.01 g CaCl.6H2O, 2 g NaHCO3, 2 mL Tween 80, 0.05 g haemin, 0.01 mL vitamin K1, 0.5 174 
g L-cysteine-HCl, 0.5 g bile salt and 4 mL resazurin solution (0.25 g/L).  175 
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The fermentation of each substrate was carried out in triplicate with each of three 176 
healthy human faecal donors, who had not taken prebiotic or probiotic products for 3 177 
months, or antibiotics for six months prior to the study. Each vessel containing 178 
fermentation medium was inoculated with 5 mL of faecal slurries, which was prior diluted 179 
at 10 % (w/w) with anaerobic phosphate-buffered saline (PBS, 0.1 M) and homogenised in 180 
a stomacher (Stomacher 400; Seward, West Sussex, UK) for 2 min at medium speed.  181 
The fermentation was carried out at pH 6.7-6.9, controlled using an automated pH 182 
controller (Fermac 260; Electrolab, Tewkesbury, UK) and at 37 oC (using a 183 
thermocirculator) under anaerobic atmosphere, which was achieved through continuous 184 
sparging with nitrogen gas. Samples (5 mL) were taken from each fermentation vessel at 0, 185 
10, 24 and 36 h for organic acid analysis and bacterial enumeration using the fluorescent in 186 
situ hybridisation (FISH) technique. 187 
 188 
2.6 Enumeration of bacteria 189 
The target faecal bacteria groups were enumerated by FISH using 16S rRNA 190 
targeted oligonucleotide probes labelled with the fluorescent Cy3 dye. An aliquot (375 µL) 191 
of sample from each sampling time was mixed with 3 volumes of 4 % (w/v) cold 192 
paraformaldehyde (PFA) solution. The duration of fixation was 5-10 h at 4 oC, followed by 193 
centrifugation at 13 000 x g for 5 min; the cell pellet was then washed twice with 1 mL cold 194 
filter sterilised PBS. The washed cells were then resuspended in 150 µL PBS and 150 µL of 195 
absolute ethanol and stored at -20 oC until analysis.  196 
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To further process the PFA-fixed sample, 10 µL of each sample was diluted with 197 
PBS/SDS (sodium dodecyl sulphate) diluent and the diluted samples (20 µL) were applied 198 
onto six-well of a polytetrafluoroethylene/poly-ι-lysine coated slide (Tekdon Inc., Myakka 199 
City, FL). The samples were dried at 48 oC for 15 min in a desktop plate incubator and then 200 
dehydrated using a series of ethanol solution at 50 %, 80 % and 96 % (v/v) for 3 min each. 201 
The excess ethanol was evaporated by drying the slides in a desktop plate incubator for 2 202 
min followed by addition of 50 µL of mixed hybridisation solution (5 µL oligonucleotide 203 
probe solution and 45 µL hybridisation buffer) onto each well. The slide with samples were 204 
hybridised in a microarray hybridisation incubator (Grant-Boekel, Cambridge, UK) for 4 h, 205 
washed in 50 mL washing buffer for 15 min and dipped in cold distilled water for 2 s. 206 
Slides were dried with compressed air and a drop of PVA-DABCO antifade (polyvinyl 207 
alcohol mounting medium with 1, 4-diazabicyclo (2.2.2) octane) was added onto each well. 208 
The microscope cover slip was placed on each slide and the cell numbers of 209 
microorganisms were determined by direct counting under an epifluorescence microscope 210 
(Eclipse 400; Nikon, Surrey, UK) with Fluor 100 lens. A total of 15 fields of view were 211 
counted for each well.  212 
The probes used were Bif164 (Langendijk et al., 1995), Bac303 (Manz, Amann, 213 
Ludwig, Vancanneyt & Schleifer, 1996), Lab158 (Harmsen, Elfferich, Schut & Welling, 214 
1999), Ato291 (Harmsen, et al., 2000), Prop853 (Walker, Duncan, McWilliam Leitch, 215 
Child & Flint, 2005), Erec482 (Franks et al., 1998), Rrec584 (Walker et al., 2005), 216 
Fprau655 (Hold, Schwiertz, Aminov, Blaut & Flint, 2003), Chis150 (Franks et al., 1998), 217 
and mixed Eub338 I, II, III (Daims, Brühl, Amann, Schleifer & Wagner, 1999) for 218 
enumerating Bifidobacterium spp., Bacteroides-Prevotella, Lactobacillus-Enterococcus, 219 
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Atopobium cluster, propionate producing bacteria (Clostridium cluster IX), Eubacterium 220 
rectale-Clostridium cocoides group (Clostridium cluster XIVa and XIVb), Roseburia spp., 221 
Faecalibacterium prausnitzii cluster Clostridium histolyticum group (Clostridium cluster I 222 
and II) and total bacteria, respectively. 223 
 224 
2.7 Organic acid analysis  225 
An aliquot (1 mL) of sample from each sampling time was centrifuged at 13 000 x g 226 
for 10 min and the supernatant was stored at -20 oC until analysis. Organic acids analysis 227 
was performed using an HPLC (1100 series; Agilent, Winnersh, UK) with refractive index 228 
detection. Prior to the analysis, the samples, after thawing, were centrifuged at 13 000 x g 229 
for 10 min and the supernatants were filtered through a 0.22 µm filter unit. An ion 230 
exclusion column, Rezex ROA-Organic Acid H+ (8%) (Phenomenex, Cheshire, UK) was 231 
used for the analysis, using 2.5 mM H2SO4 as eluent. The column was heated at 84 
oC and 232 
the eluent flow rate was set at 0.5 mL/min. The injection volume used was 20 L with 40 233 
min run time. Organic acids were quantified using standard calibration curves for lactate, 234 
acetate, propionate, butyrate and valerate at concentrations of 12.5, 25, 50, 75 and 100 mM. 235 
Formate was determined using a formate dehydrogenase-based assay kit (Megazyme, 236 
Ireland). 237 
 238 
2.8 Carbohydrate assimilation profile during fermentation 239 
The assimilation profile for the nine different carbohydrates substrates used for the 240 
batch culture fermentations was determined by High Performance Anion-Exchange 241 
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Chromatography (HPAEC, Dionex, Camberley, UK) using a CarboPac PA-1 column and 242 
Pulsed Amperometric Detection (PAD). Samples were filtered and diluted with deionised 243 
water at a dilution factor of 30. The injection volume was 25 L and the flow rate 1 244 
mL/min with the following linear gradient: 8.75 mM NaOH and 2.4 mM sodium acetate 245 
from 0-19 min; 30 mM NaOH and 25 mM sodium acetate from 20-44 min; and 96.875 mM 246 
NaOH and 150 mM sodium acetate from 45-49 min. After 50 minutes, a washing step was 247 
performed with 125 mM NaOH and 500 mM sodium acetate for 10 min and the column 248 
was then equilibrated for 20 min with 8.75 mM NaOH and 2.4 mM sodium acetate. 249 
Standard glucose, arabinose, xylose and xylose oligomers (DP 2-6, Megazyme, Ireland) 250 
were used for identification.  251 
 252 
2.9 Statistical analysis 253 
Statistical analysis was performed using SPSS for Windows, version 17.0. One-way 254 
analysis of variance (ANOVA) and Tukey’s posthoc test was used to determine significant 255 
differences among the bacterial group populations and organic acid concentrations among 256 
the different substrates. A paired independent t-test was also used to determine significant 257 
changes for each bacterial group concentration at inoculation and subsequent sampling 258 
point. Differences were considered to be significant when p<0.05. 259 
 260 
3. Results and discussion 261 
3.1 Characterization of the XOS/XPS fractions 262 
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The chemical analysis of the six fractions of purified and freeze dried OPEFB 263 
autohydrolysis liquor is shown in Table 1.  In all cases, XOS/XPS were the dominant  264 
 265 
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Table 1  266 
Composition of OPEFB fibre fractions (g/100 g freeze dried sample) obtained after GFC purificationa 267 
 268 
Sample 
no. 
avDPb Residues in linkage (g/100 g) Ratioc Free Monomers    
(g/100 g) 
Total phenolics 
(g/100 g) 
Glc Xyl Ara AcO Ara/Xyl AcO/Xyl Xylose Acetic acid 
1 4 1.75 62.25 1.49 9.16 0.02 0.37 1.23 1.73 0.46 
2 7 1.62 65.38 1.16 10.30 0.02 0.39 0.86 0.80 0.37 
3 14 1.56 67.32 1.22 11.23 0.02 0.42 0.65 0.48 0.33 
4 28 1.61 67.68 1.18 12.43 0.02 0.46 0.57 0.46 0.31 
5 44 2.31 64.00 1.21 12.75 0.02 0.50 n.d 0.48 0.43 
6 64 2.83 59.28 1.16 12.95 0.02 0.55 n.d 0.46 0.43 
 
aIn freeze dried form and  reconstitute with deionised water to give final concentration of 10 g/L. Calculations were made 
by assuming the freeze dried samples have 5% moisture content. 
bavDP – Average degree of polymerization as determined by size exclusion chromatography 
cRatio in mol/mol 
AcO - acetyl groups linked to oligosaccharides; n.d. – not detected 
  269 
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oligosaccharides, accounting for 78-83 % of the total oligosaccharides. The highest 270 
XOS/XPS yield was found in the middle fractions (avDP 14 and 28); free monomeric 271 
compounds (xylose and acetic acid) were present at slightly higher concentrations in XOS 272 
fractions with lower DP (avDP 4 and 7) than in the other fractions with free xylose absent 273 
in XPS fractions with higher DP (avDP 44 and 64). The oligosaccharides of the higher DP 274 
fractions (XPS, avDP 44 and 64) were more acetylated. The acetyl groups contribute to the 275 
oligosaccharides solubility in water (Nabarlatz, Ebringerová & Montané, 2007) and this 276 
may be the reason that high molecular weight XOS fractions were present in OPEFB 277 
autohydrolysis liquor. The arabinose content was rather low for all fractions, with an 278 
arabinose to xylose ratio of approximating 0.02. The gluco-oligosaccharides (GlcOS) were 279 
presumably derived from cellulose and were present at 2-3% w/w. There was also a small 280 
amount of total phenolic compounds (<0.5 % w/w) found in all samples.  281 
 OPEFB fractions (avDP 4, 7 and 14) were analysed by MALDI-ToF-MS (larger 282 
avDP fractions were too large for MALDI-ToF-MS analysis). XOS/XPS fractions were all 283 
analysed in both their native and permethylated forms by MALDI-ToF-MS.  All XOS/XPS 284 
fractions analysed in their native form showed acetylated pentose oligosaccharide ions 285 
(labelled PentnAcn, the n denoting the number of pentose (Pent) or acetyl (Ac) groups 286 
respectively). In avDP 4 the most dominant ion is m/z 917.27 (Pent6Ac2) (Fig. 1) with 287 
acetylated oligosaccharides ranging from Pent4Ac2 (m/z 653.19) to Pent9Ac4 (m/z 1397.42). 288 
Also present are pentose oligosaccharides with no acetylation or other modifications with 289 
DP 6 to 9 (m/z 833.25 to 1229.38) and hexose oligosaccharides of DP 4-8 (m/z 689.21 to 290 
1337.42). There could also be small pentose oligosaccharides with methylated-glucuronic 291 
acid substitutions (ions at m/z 637.18 and 685.18) found in the native avDP 4 fraction.  The 292 
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permethylated version of avDP 4 fraction (data not shown); although the acetylated 293 
residues of the pentose oligosaccharides are lost, we were able to see a pentose ladder 294 
starting from Pent3 (m/z 549.25) up to Pent9 (m/z 1509.69) and ladder of pentose 295 
oligosaccharide substituted with single glucuronic acid up to DP 8 (Pen1HexA1, m/z 447.18 296 
to Pen7HexA1, m/z 1407.63) that could not be observed in native form of the sample. 297 
Similarly to the native version of avDP 4 XOS fraction hexose oligosaccharide ladder was 298 
observed (Hex3 m/z 681.33- Hex8 m/z 1701.83) These data confirm the data in Table 1 299 
which showed gluco-oligosaccharides (hexose oligosaccharides), xylo- and arabino-300 
oligosaccharides (pentose oligosaccharides) and acetylated oligosaccharides. Mass 301 
spectrometry of OPEFB fractions of avDP 7 and avDP 14 also confirmed the data in Table 302 
1. The predominant ions were the acetylated pentoses e.g. m/z 785.18 (Pent5Ac2) up to 303 
Pent9Ac5 ion (m/z 1439.43) and methylated glucuronic acid substituted oligosaccharides 304 
were also present (m/z 637.18 and m/z 685.18) (Supplementary Fig. 1a). The permethylated 305 
avDP7 fraction (Supplementary Fig. 1b) also contained hexose oligosaccharides (Hex4, m/z 306 
885.43 to Hex10 m/z 2110.03) as well as pentose oligosaccharide substituted with 307 
glucuronic acid (Pent2HexA1, m/z 607.26 to Pent9HexA1, m/z 1727.77). In OPEFB the 308 
avDP 14 fraction (Supplementary Fig. 1c) acetylated pentose oligosaccharides range from 309 
Pent5Ac2, m/z 785.23 to Pent18Ac6, m/z 2669.82.  Also, observed in the permethylated 310 
avDP14 (Supplementary Fig.1d) are glucuronic acid substituted pentoses, Pent3HexA1 (m/z 311 
767.33) to Pent13HexA1 (m/z 2368.07).  312 
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 313 
Fig. 1. MALDI-ToF-MS spectrum of native glycans isolated from OPEFB XOS fraction avDP 4. The glycan adduct ions 314 
[M+Na]+ are indicated for acetylated pentose oligosaccharides (PentnAcn), for pentose oligosaccharides (Pentn), for pentoses with 315 
methylated-glucuronic acid substitution (PentnMetHexAnAcn) and for hexose oligosaccharides (Hexn).  316 
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The DP ranges of the OPEFB fractions obtained from MALDI-ToF-MS analysis 317 
were as follows: avDP 4 (DP 2-9), avDP 7 (DP 3-12), avDP 14 (DP 3-18). The OPEFB 318 
fractions were also xylanase cleaved and visualised by polysaccharide analysis using 319 
carbohydrate gel electrophoresis (PACE) (Fig.2) which confirms the predominant 320 
oligosaccharides were xylo-oligosaccharides and that the gel filtration fractionation of the 321 
avDP 4 to avDP 64 contained similar oligosaccharides but with increasing xylose chain 322 
length. 323 
 324 
             325 
 326 
Fig. 2. PACE gel showing separation of extracted OPEFB XOS fractions digested with 327 
Xyn11 and undigested. S - Standard xylose1-6 ladder; 4-5 = avDP 4; 14 = avDP 14; 28 = 328 
avDP 28 and 64 = avDP 64, digested with Xyn11.  4-5 = avDP 4; 7 = avDP 7; 14 = avDP 329 
14; 28 = avDP 28; 44 = avDP 44 and 64 = avDP 64, undigested OPEFB XOS fractions. 330 
19 
 
3.2 Bacterial enumeration 331 
Changes in the bacterial populations during the in vitro fermentations with the 332 
different XOS fractions are shown in Table 2. A significant increase (p<0.05) of 333 
Bifidobacterium population, ranging between 0.5-0.8 log cells/mL for all time points 334 
compared to time 0 h was observed for the XOS fractions with avDP of 4, 7 and 14, 335 
commercial XOS and FOS. In the case of the XOS fractions with avDP of 28 and 44, 336 
significant increases (p<0.05) were observed for the 10 h sample, whereas for the XOS 337 
fraction with avDP of 64, although an increase was observed for the 10 h sample, this was 338 
not statistically significant (p≥0.05). For all these higher avDP (28, 44, 64) fractions, the 339 
concentrations were sustained for the 24 h and 36 h samples and were not statistically 340 
different to 0 h. Taking into account the above and the fact that the effect of the XOS 341 
fractions with low avDP (avDP 4-14) on the Bifidobacterium population was similar to that 342 
of commercial XOS, which mainly consists of DP 2-3, it can be inferred that bifidobacteria 343 
preferred the lower molecular weight XOS fractions. This is also supported by the fact that 344 
birch wood xylan did not have a significant effect on the Bifidobacterium population. In the 345 
pure culture study, there were few strains of Bifidobacterium capable of fermenting high 346 
molecular weight XOS or xylan (Palframan, Gibson & Rastall, 2003b). The reason for the 347 
increase in the Bifidobacterium population at 10 h for the XOS fractions of avDP 14, 28, 44 348 
could be that the bifidobacteria utilise the low molecular weight XOS, which were present 349 
in the fractions as demonstrated by the MALDI-ToF-MS. Another possibility is that higher 350 
molecular weight XOS was hydrolysed to smaller XOS molecules by other microorganisms 351 
such as Bacteroides (Chassard, Goumy, Leclerc, Del'homme & Bernalier-Donadille, 2007;   352 
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Table 2  
Mean bacterial populations in pH-controlled batch cultures at 0, 10, 24 and 36 ha 
Probe Time (h) Bacterial population (log10 cells/ml batch culture fluid) in substrate 
OPEFB XOS 
(avDP 4) 
OPEFB XOS 
(avDP 7) 
OPEFB XOS 
(avDP 14) 
OPEFB XPS 
(avDP 28) 
OPEFB XPS 
(avDP 44) 
OPEFB XPS 
(avDP 64) 
Birch wood 
xylan 
XOS  
(SLBC) 
FOS 
(Raftilose) 
Bif164 
 
7.85(0.09) 
10 
24 
36 
8.38 (0.19)ab* 
8.56 (0.14)a* 
8.41 (0.15)a* 
8.37 (0.18)ab* 
8.50 (0.19)a* 
8.46 (0.13)a* 
8.41 (0.27)ab* 
8.59 (0.16)a* 
8.54 (0.10)a** 
8.31 (0.16)ab* 
8.40 (0.29)a 
8.30 (0.24)a 
8.26 (0.16)ab* 
8.36 (0.28)a 
8.24 (0.21)a 
8.22 (0.10)ab 
8.29 (0.28)a 
8.10 (0.21)a 
8.15 (0.10)a 
8.25 (0.29)a 
8.01 (0.23)a 
8.65 (0.13)b** 
8.53 (0.06)a** 
8.38 (0.19)a* 
8.64 (0.08)b** 
8.48 (0.12)a* 
8.31 (0.35)a 
Bac303 
 
8.10(0.09) 
10 
24 
36 
8.58 (0.08)a* 
8.50 (0.14)a** 
8.30 (0.17)a 
8.62 (0.17)a 
8.50 (0.06)a** 
8.31 (0.12)a 
8.64 (0.27)a 
8.71 (0.04)a* 
8.46 (0.04)a** 
8.62 (0.13)a* 
8.59(0.25)a* 
8.33 (0.32)a 
8.46 (0.26)a 
8.50 (0.44)a 
8.43 (0.29)a 
8.43 (0.14)a* 
8.41 (0.50)a 
8.27 (0.46)a 
8.48 (0.34)a 
8.59 (0.35)a 
8.32 (0.14)a* 
8.54 (0.11)a 
8.42 (0.13)a* 
8.29 (0.20)a 
8.63 (0.20)a 
8.46 (0.21)a 
8.15 (0.08)a 
Lab158 
 
7.97(0.04) 
10 
24 
36 
8.30 (0.19) a 
8.36 (0.17) a 
8.31 (0.17) a 
8.42 (0.25) a 
8.50 (0.19) a* 
8.45 (0.12) a* 
8.45 (0.23) a* 
8.57 (0.20) a* 
8.46 (0.14) a* 
8.45 (0.20) a* 
8.46 (0.07) a** 
8.27 (0.11) a 
8.38 (0.26) a 
8.29 (0.35) a 
8.10 (0.31) a 
8.29 (0.05) a* 
8.24 (0.24) a 
8.04 (0.32) a 
8.27 (0.14) a 
8.42 (0.19) a* 
8.13 (0.19) a 
8.51 (0.13) a* 
8.35 (0.14) a* 
8.28 (0.24) a 
8.45 (0.22) a 
8.30 (0.15) a* 
8.32 (0.35) a 
Ato291 
 
7.78(0.10) 
10 
24 
36 
8.22 (0.03)ab* 
8.14 (0.09)bcd* 
7.88 (0.23)abc 
8.19 (0.05)ab* 
8.08 (0.10)abc** 
7.80 (0.17)ab 
8.12(0.05)ab** 
7.93 (0.11)ab 
7.81 (0.16)ab 
8.07 (0.18)a 
7.99 (0.03)abc* 
7.69 (0.10)a 
8.00 (0.07)a 
7.87 (0.04)ab 
7.60 (0.15)a 
8.05 (0.14)a 
7.72 (0.05)a 
7.57 (0.15)a 
7.97 (0.32)a 
8.00 (0.20)abc 
7.66 (0.21)a 
8.42 (0.17)ab** 
8.35 (0.20)cd* 
8.22 (0.24)bc 
8.56 (0.20)b** 
8.51 (0.23)d** 
8.37 (0.05)c** 
Prop853 
 
7.71(0.05) 
10 
24 
36 
7.90 (0.04)a* 
8.03 (0.26)a 
7.87 (0.33)a 
8.07 (0.12)a 
8.12 (0.09)a* 
7.92 (0.16)a 
8.08 (0.08)a* 
8.17 (0.08)a* 
7.86 (0.19)a 
8.11 (0.05)a** 
8.13 (0.14)a* 
7.78 (0.13)a 
8.05 (0.03)a** 
8.04 (0.30)a 
7.74 (0.41)a 
8.01 (0.23)a 
7.87 (0.37)a 
7.68 (0.41)a 
7.92 (0.32)a 
7.98 (0.23)a 
7.76 (0.20)a 
7.99 (0.23)a 
8.02(0.32)a 
7.61 (0.12)a 
7.97 (0.25)a 
7.97 (0.37)a 
7.86 (0.24)a 
Erec482 
 
7.99(0.04) 
10 
24 
36 
8.09 (0.20) a 
8.26 (0.12) a* 
8.43 (0.10) a* 
8.18 (0.47) a 
8.44 (0.34) a 
8.41 (0.33) a 
8.28 (0.48) a 
8.35 (0.51) a 
8.27 (0.47) a 
8.29 (0.37)a 
8.43(0.27) a 
8.28 (0.09) a* 
8.15 (0.18) a 
8.08 (0.52) a 
8.19 (0.32) a 
8.20 (0.14) a 
8.22 (0.27) a 
8.13 (0.41) a 
8.20 (0.18) a 
8.24 (0.14) a* 
8.20 (0.33) a 
8.28 (0.30) a 
8.36 (0.15) a* 
8.28 (0.14) a* 
8.31 (0.24) a 
8.33 (0.08) a** 
8.14 (0.12) a 
Rrec584 
 
7.38(0.05) 
10 
24 
36 
7.48 (0.16) a 
7.61 (0.06)ab 
7.70 (0.22)a* 
7.48 (0.11) a 
7.58 (0.11) ab 
7.65 (0.15) a 
7.49 (0.18) a 
7.46 (0.19)a 
7.65 (0.21) a 
7.45 (0.02) a* 
7.54 (0.10) ab 
7.53 (0.07) a* 
7.38 (0.02) a* 
7.51 (0.17)ab 
7.59 (0.20) a 
7.35(0.06) a* 
7.50(0.06) a 
7.60 (0.12) a 
7.38 (0.12) a 
7.50(0.15) a 
7.40 (0.20) a 
7.52(0.22) a 
7.85 (0.05) b* 
7.87 (0.20) a* 
7.41 (0.17) a 
7.76 (0.11) ab* 
7.75 (0.15) a 
Fprau655 
 
7.54(0.10) 
10 
24 
36 
7.58 (0.26) a 
7.36 (0.08) a 
7.44 (0.24) a 
7.67 (0.29) a 
7.45 (0.11) a 
7.46 (0.02) a 
7.66 (0.30) a 
7.57 (0.24) a 
7.47 (0.21) a 
7.72 (0.13) a 
7.84 (0.10) a* 
7.56 (0.19) a 
7.61 (0.19) a 
7.51 (0.27) a 
7.40 (0.11) a* 
7.62 (0.13) a 
7.58 (0.22) a 
7.55 (0.27) a 
7.65 (0.30) a 
7.74 (0.27) a 
7.48 (0.28) a 
7.53 (0.26) a 
7.49 (0.20) a 
7.34 (0.12) a 
7.67 (0.34) a 
7.60 (0.22) a 
7.43 (0.25) a 
Chis150 
 
7.33(0.05) 
10 
24 
36 
7.41 (0.21)a 
7.34 (0.04)a 
6.93 (0.12)a 
7.48 (0.09)a 
7.34 (0.15)a 
6.97 (0.08)a* 
7.44 (0.13)a 
7.23 (0.06)a 
6.95 (0.15)a 
7.49 (0.10)a 
7.31 (0.10)a 
6.91 (0.06 )a* 
7.38 (0.07)a 
7.27 (0.05)a 
6.90 (0.16)a 
7.38 (0.15 )a 
7.24 (0.07)a 
6.71 (0.07)a* 
7.44 (0.09)a 
7.36 (0.09)a 
6.95 (0.15)a* 
7.36 (0.11)a 
7.28 (0.03)a 
6.88 (0.08)a* 
7.56 (0.27)a 
7.34 (0.12)a 
6.80 (0.06 )a* 
Eub338 
 
8.79(0.06) 
10 
24 
36 
9.17 (0.11) a 
9.25(0.17) a 
9.16(0.19) a 
9.21 (0.12) a* 
9.25 (0.10) a* 
9.15(0.15) a 
9.22 (0.10) a* 
9.30 (0.14) a* 
9.22 (0.13) a 
9.19 (0.06) a* 
9.25 (0.13) a* 
9.08 (0.05) a* 
9.16 (0.15) a 
9.24 (0.18) a 
9.08 (0.34) a 
9.10 (0.10) a* 
9.12 (0.13) a 
8.93 (0.33) a 
9.06 (0.14) a 
9.12 (0.16) a 
8.91 (0.19) a 
9.33 (0.18) a 
9.27 (0.16) a 
9.09 (0.17) a 
9.30 (0.11) a* 
9.18 (0.11) a 
9.06 (0.13) a 
aStandard deviation is shown in parentheses (n=3). Significant differences (p<0.05) between substrates are indicated with different letters in a same row. 
*Significant differences from value at 0 h, p<0.05; **Significant differences from value at 0 h, p<0.01 (Value at 0 h is shown in the far left under ‘Probe’ column) 
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Falony, Calmeyn, Leroy & De Vuyst, 2009). This was also observed in studies carried out 354 
by Mäkeläinen and co-workers (2010a; 2010b), a high molecular weight xylan (DP 35-40) 355 
was not efficiently metabolised by a range of Bifidobacterium strains in pure culture studies 356 
but when they tested the same xylan in a semi continuous colon simulator system using 357 
faecal inoculum, they observed a significant increase in the Bifidobacterium sp. population.  358 
Another bacterial group which had significant difference between substrates is the 359 
Atopobium cluster. Atopobium has the highest count on FOS, significantly higher (p<0.05) 360 
than OPEFB XOS of avDP 28, 44 and 64. These results are consistent with Hughes et al. 361 
(2007) whereby the large molecular weight AXOS (278 kDa and 354 kDa) generally did 362 
not induce growth of Atopobium. 363 
 364 
3.3 Organic acid analysis 365 
Table 3 shows the organic acid concentrations in the fermentations; acetate was the 366 
leading SCFA produced, followed by propionate, formate, lactate and butyrate. Across all 367 
substrates, formate and lactate were transient metabolites reaching maximum at 10 h. 368 
Acetate and propionate concentration on the other hand continued to rise up to 24 h and/or 369 
36 h, whereas butyrate, though present at low concentration initially, increased steadily up 370 
to 36 h.  371 
All OPEFB XOS produced significantly lower (p<0.05) amount of lactate than 372 
commercial XOS and FOS. The wider DP distribution and possibility the presence of 373 
substituents on OPEFB XOS may affect the accessibility for bifidobacterial fermentation. 374 
Kabel et al. (2002a) also observed a higher amount of lactate in non-substituted XOS than 375 
22 
 
substituted XOS. According to Falony et al. (2009), metabolism in bifidobacteria produces 376 
more formate, acetate and ethanol at the expense of lactate when there is limited access to 377 
substrate. Different carbohydrates are known to promote the growth of different species of 378 
bifidobacteria, resulting in varying amount of lactate (Palframan et al., 2003b).  379 
The initial acetate level in OPEFB XOS avDP 4 was high, possibly as a result of 380 
free acetic acid present in the low molecular weight substrate. XOS in all OPEFB fractions 381 
and the commercial XOS resulted in higher acetate and less propionate and butyrate than 382 
FOS. This typical profile corresponds with previous studies conducted on XOS and xylan 383 
fermentation (Englyst, Hay & Macfarlane, 1987; Kabel et al., 2002a; Rycroft, Jones, 384 
Gibson & Rastall, 2001).  385 
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Table 3  
Mean organic acid concentrations in pH-controlled batch cultures at 0, 10, 24 and 36 ha 
 Organic 
acid 
Time 
(h) 
Concentration (mM)  
OPEFB XOS  
(avDP 4) 
OPEFB XOS  
(avDP 7) 
OPEFB XOS  
(avDP 14) 
OPEFB XPS  
(avDP 28) 
OPEFB XPS  
(avDP 44) 
OPEFB XPS  
(avDP 64) 
Birch wood 
xylan 
XOS (Suntory) FOS (Raftilose) 
Lactate 0 
10 
24 
36 
0.00 (0.00)a 
4.88 (2.92)a 
0.56 (0.98)a 
0.00 (0.00)a 
0.00 (0.00)a 
1.85 (2.32)a 
0.32 (0.56)a 
0.00 (0.00)a 
0.00 (0.00)a 
2.46 (2.38)a 
1.02 (1.76)a 
0.00 (0.00)a 
0.00 (0.00)a 
0.81 (1.40)a 
0.00 (0.00)a 
0.00 (0.00)a 
0.00 (0.00)a 
2.34 (1.44)a 
0.50 (0.87)a 
0.45 (0.78)a 
0.00 (0.00)a 
0.46 (0.79)a 
0.00 (0.00)a 
0.00 (0.00)a 
0.00 (0.00)a 
0.79 (0.72)a 
0.32 (0.56)a 
0.47 (0.81)a 
0.78 (0.68)a 
16.11 (5.89)b* 
0.00 (0.00)a 
0.00 (0.00)a 
0.79 (0.68)a 
19.29 (6.34)b* 
0.00 (0.00)a 
0.00 (0.00)a 
Formate 0 
10 
24 
36 
0.58 (0.04)d 
8.42 (8.28)a 
5.33(3.65)a 
0.00 (0.00)a 
0.16 (0.07)bc 
7.61 (7.02)a 
5.66 (8.32)a 
1.93 (3.34)a 
0.11 (0.07)abc 
4.26 (5.39)a 
3.54(6.12)a 
0.55 (0.95)a 
0.11 (0.06)abc 
8.37 (6.06)a 
4.26 (7.38)a 
0.00 (0.00)a 
0.13 (0.06)abc 
4.11 (5.44)a 
6.44 (5.58)a 
2.34 (2.54)a 
0.36 (0.04)a 
5.80 (7.78)a 
2.19 (3.56)a 
0.00 (0.00)a 
0.16 (0.03)c 
2.64 (1.64)a 
0.05 (0.08)a 
0.00 (0.00)a 
0.03 (0.04)ab 
14.06 (3.49)a* 
6.56 (5.94)a 
1.24 (2.15)a 
0.01 (0.01)a 
14.96(5.90)a* 
1.69 (2.86)a 
0.00 (0.00)a 
Acetate 
(A) 
0 
10 
24 
36 
10.08 (2.41)c 
48.44 (21.23)a 
77.39 (21.26)b* 
79.80 (22.19)b* 
6.70 (1.79)bc 
47.45 (24.27)a 
71.61 (7.48)ab** 
68.68 (10.00)ab** 
6.00 (1.56)b 
47.84 (23.12)a 
78.37 (6.57)b** 
78.70 (6.86)b** 
5.62 (1.72)ab 
51.72 (24.48)a 
62.35 (11.82)ab* 
54.60 (10.09)ab* 
5.20 (0.50)ab 
33.12 (22.07)a 
57.30 (28.36)ab 
59.49 (27.07)ab 
5.18 (0.38)ab 
37.19 (27.31)a 
43.50 (26.36)ab 
41.44 (30.12)ab 
5.84 (0.06)ab 
25.53 (6.71)a* 
28.98 (7.96)a* 
21.32 (7.03)a 
2.18 (0.03)a 
54.82 (8.47)a** 
60.19 (2.00)ab** 
60.53 (3.77)ab** 
2.31 (0.30)a 
47.55 (11.02)a* 
43.10 (6.47)ab** 
39.61 (7.66)ab* 
Propionate 
(P) 
0 
10 
24 
36 
3.08 (0.52)a 
9.23 (4.64)a 
16.57 (4.75)a* 
17.93 (5.55)a* 
2.75 (0.19)a 
13.84 (10.69)a 
20.10 (7.20)a 
18.82 (6.41)a* 
2.69 (0.18)a 
15.60 (11.96)a 
25.10 (8.72)a* 
25.70 (7.51)a* 
2.67 (0.19)a 
12.77 (1.82)a* 
18.43 (2.87)a* 
16.35 (2.54)a* 
2.70 (0.10)a 
7.96 (1.94)a* 
18.15 (10.37)a 
19.27 (11.63)a 
2.69 (0.22)a 
11.37 (6.05)a 
11.46 (10.51)a 
11.28 (11.08)a 
2.76 (0.18)a 
10.28 (2.78)a* 
13.22 (4.72)a 
9.91 (3.20)a 
2.61 (0.11)a 
13.28 (8.04)a 
18.07 (8.97)a 
17.96 (9.82)a 
2.67 (0.42)a 
15.55 (14.71)a 
18.58 (16.11)a 
18.22 (16.91)a 
Butyrate 
(B) 
0 
10 
24 
36 
0.00 (0.00)a 
1.11 (1.72)a 
2.99 (1.81)a 
4.07 (1.75)ab 
0.00 (0.00)a 
1.85 (1.84)a 
3.08 (2.13)a 
3.52 (2.31)a 
0.00 (0.00)a 
1.87 (2.33)a 
3.32 (3.40)ab 
4.49 (4.11)ab 
0.00 (0.00)a 
2.08 (1.47)a 
3.67 (1.74)ab 
4.09 (1.03)ab* 
0.00 (0.00)a 
1.11 (1.44)a 
1.66 (1.46)a 
2.40 (2.02)a 
0.00 (0.00)a 
1.89 (1.06)a 
2.66 (2.48)a 
3.24 (3.60)a 
0.00 (0.00)a 
1.76 (0.86)a 
3.39 (1.92)ab 
3.09 (2.79)a 
0.00 (0.00)a 
1.89 (1.65)a 
11.41 (5.31)bc 
12.30 (4.64)bc* 
0.00 (0.00)a 
2.68 (1.08)a* 
13.16 (3.29)c* 
13.23 (2.49)c* 
Total 0 
10 
24 
36 
13.73 (2.70)b 
72.09(29.09)a 
102.84 (27.40)a* 
101.80(26.14)ab* 
9.61 (1.85)ab 
72.60 (33.75)a 
100.77 (7.09)a** 
92.95 (6.64)ab** 
8.80 (1.65)a 
72.03 (32.92)a 
111.35 (6.55)a** 
109.44 (2.12)b** 
8.40 (1.87)a 
75.74 (32.56)a 
88.71 (21.28)a* 
75.04 (12.69)ab* 
8.04 (0.42)a 
48.64 (27.61)a 
84.05 (44.15)a 
83.96 (41.10)ab 
8.23 (0.56)a 
56.71 (41.11)a 
59.80 (42.27)a 
55.95 (44.40)ab 
8.77 (0.22)a 
41.00(11.33)a* 
45.97(13.62)a* 
34.79 (12.76)a 
5.59 (0.67)a 
100.15 (7.69)a** 
96.24 (4.10)a** 
92.03 (7.57)ab** 
5.77 (1.38)a 
100.03 (1.46)a** 
76.52 (10.92)a** 
71.05 (17.60)ab* 
A:P:B 0 
10 
24 
36 
1:0.3:0 
1:0.2:0.03 
1:0.2:0.04 
1:0.2:0.05 
1:0.4:0 
1:0.3:0.03 
1:0.3:0.04 
1:0.3:0.05 
1:0.5:0 
1:0.3:0.03 
1:0.3:0.04 
1:0.3:0.06 
1:0.5:0 
1:0.3:0.04 
1:0.3:0.06 
1:0.3:0.08 
1:0.5:0 
1:0.3:0.04 
1:0.3:0.04 
1:0.3:0.05 
1:0.5:0 
1:0.3:0.06 
1:0.3:0.06 
1:0.3:0.06 
1:0.5:0 
1:0.4:0.07 
1:0.5:0.1 
1:0.5:0.1 
1:1.2:0 
1:0.3:0.03 
1:0.3:0.2 
1:0.3:0.2 
1:1.2:0 
1:0.4:0.06 
1:0.5:0.3 
1:0.5:0.4 
aStandard deviation is shown in parentheses with n=3. Significant differences (p<0.05) between substrates are indicated with different letters in a same row. 
*Increased significantly from value at 0 h, p<0.05; **Increased significant differences from value at 0 h, p<0.01 
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The significant increase in acetate at 24 h and 36 h for XOS of avDP 4, 7, 14 and 28 387 
can be linked to the two major acetate producers; Bifidobacterium spp. and the Bacteroides-388 
Prevotella group.  389 
There was no significant increase in butyrate on any OPEFB XOS while 390 
commercial XOS resulted in similar butyrate level to FOS (p≥0.05). Nevertheless, the XOS 391 
preparation of lower avDP (4, 14, 28) were not different to commercial XOS (p≥0.05).  392 
Although the human gut microbiota has also been known to be able to further metabolise 393 
acetate to butyrate (Duncan, Barcenilla, Stewart, Pryde & Flint, 2002; Duncan et al., 2004), 394 
the conversion of acetate from OPEFB XOS to butyrate was generally lower.  395 
The type and molecular weight of the substrates influenced rate and amount of 396 
organic acid produced. Based on total organic acid, it is noticeable that commercial XOS 397 
and FOS were the fastest fermentable substrates, reaching at least 100 mM at 10 h. As for 398 
OPEFB XOS, the three lowest avDP (4, 7, 14) reached 100 mM at 24 h while other 399 
fractions of higher avDP (28, 44, 64) had less than 100 mM and birch wood xylan, the least 400 
fermentable substrate had the lowest organic acid of all with 46 mM at 24 h. 401 
 402 
3.4 Carbohydrate assimilation profile during fermentation 403 
The carbohydrate was profiled in the samples during the course of fermentation using 404 
HPAEC-PAD to observe the changes in DP. The assimilation profile of OPEFB XOS of 405 
avDP14 from each faecal donor is illustrated in Fig. 3. The three donors showed slight 406 
variation in magnitudes and trends that coincides with rather high standard deviation 407 
observed in the organic acid data. At 10 h, donor 1 XOS were utilised faster, leaving behind 408 
25 
 
xylose. For donor 2, since the rate of fermentation is slower, some oligosaccharides were 409 
still present at 10 h and without much increase of xylose. Donor 3 had a trend between 410 
donor 1 and 2 whereby the XOS were also quickly fermented and broken down into xylose, 411 
xylobiose and xylotriose. At 24 h there was no detectable sugar remaining in all the culture 412 
samples. While the xylose and low DP XOS were being consumed by the bacteria, 413 
accumulation could arise from continual digestion of XOS/XPS from the higher DP. This 414 
similar degradation characteristic was also observed in XOS (DP 2-6) derived from rice 415 
husk when fermented with a single bifidobacteria culture (Gullón et al., 2008).  416 
Analysis with HPAEC-PAD however does not provide information on acetyl groups 417 
as deacetylation occurs in the high pH eluent used in HPAEC (Kabel et al., 2002a). As such, 418 
the chromatogram could not show the susceptibility of acetylated XOS during fermentation.  419 
   420 
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 421 
Fig. 3. Degradation profile of OPEFB XOS avDP 14 at different time by faecal culture from three donors using HPAEC-PAD: 422 
(a) Substrate before fermentation, (b) Immediately after substrate addition into fermenter, (c) After 5 h, (d) After 10 h. X1, X2, 423 
X3 on the chromatogram indicate the position of xylose, xylobiose and xylotriose, respectively.  424 
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4. Conclusion 425 
The solubility of high avDP XOS/XPS preparation from OPEFB through 426 
autohydrolysis process is rather interesting as it could be incorporated into many food 427 
processes. The acetyl group may aid XOS/XPS solubility, however the impact of this on 428 
fermentation in the gut was not conclusive from the present results. Nevertheless, the 429 
degree of polymerisation has significant influence on OPEFB XOS/XPS fermentability by 430 
the gut microflora. The in vitro study conducted in this work shows the low avDP XOS (4, 431 
7, 14) were more selective to beneficial bacteria than the higher avDP XPS (22, 44, 64). 432 
OPEFB XOS fractions of avDP 14 appeared to be the most bifidogenic. 433 
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